Yes. In most cases, recent sexual partners should be assessed and treated for chlamydia and gonorrhea after a pelvic inflammatory disease (PID) diagnosis, even if they feel well or no sexually transmitted infection was found in the person with PID. Under CDC guidance, partners from the 60 days before symptoms began should be evaluated, tested, and treated; the most recent partner should be treated if contact was earlier.
Why is partner treatment important after a PID diagnosis?
Pelvic inflammatory disease is an infection affecting the upper reproductive tract, including the uterus, fallopian tubes, and ovaries. Sexually transmitted infections (STIs), particularly chlamydia and gonorrhea, can cause PID. However, other bacteria can also be involved, so a PID diagnosis does not automatically mean that an STI is responsible.
According to the NHS guidance on pelvic inflammatory disease, PID can result from sexually transmitted infections as well as bacteria that normally live in the vagina. Even so, partner evaluation and treatment remain important because an untreated chlamydia or gonorrhea infection can be passed between sexual partners.
Treating an exposed partner helps reduce the chance that the person receiving PID treatment will become infected again. It also helps prevent the infection from spreading to other sexual partners. Treating the person with PID alone may not address an infection carried by their partner.
Which sexual partners should be tested and treated?
According to the Centers for Disease Control and Prevention (CDC) PID treatment guidelines, sexual partners who had sexual contact with a person with PID during the 60 days before symptoms began should be evaluated, tested, and presumptively treated for chlamydia and gonorrhea. Presumptive treatment means starting treatment based on the exposure and clinical guidance rather than waiting for a positive test result.
The CDC also recommends treating the most recent sexual partner when the last sexual contact occurred more than 60 days before symptom onset or diagnosis. This guidance applies regardless of which organism was detected or whether testing identified a specific cause of the PID.
Working out the relevant dates can be difficult, especially when symptoms developed gradually. Sharing the timing of recent sexual contacts with the healthcare professional can help determine which partners need to be contacted. If there have been multiple partners, tell the clinician so that each relevant exposure can be considered.
Does a partner need treatment if they have no symptoms?
Yes, a partner may need treatment even when they feel completely well. Chlamydia and gonorrhea can cause infections without obvious symptoms, so the absence of pain, discharge, or urinary problems does not rule out an infection.
The CDC recommends partner evaluation, testing, and presumptive treatment for chlamydia and gonorrhea after a PID diagnosis, regardless of the suspected cause of PID. A negative test in the person receiving PID treatment does not necessarily eliminate the need to assess exposed partners.
Partners should not wait for symptoms to appear before seeking care. A clinician can recommend appropriate tests and decide whether treatment should begin before all results are available. Testing and treatment are especially important when there has been a known exposure to an STI.
How is a partner evaluated and treated?
A sexual partner can contact a healthcare professional, primary care service, or sexual health clinic and explain that they have been exposed to an infection associated with a partner's PID diagnosis. The clinician will review the exposure, medical history, possible symptoms, and relevant health factors before recommending testing and treatment.
Testing commonly includes checks for chlamydia and gonorrhea. Depending on the circumstances, the clinician may also recommend screening for other STIs. The exact evaluation may differ according to the partner's symptoms, previous test results, pregnancy status, allergies, and other relevant medical information.
The partner's treatment is not necessarily the same as the treatment prescribed for PID. The medicines needed depend on the infection being treated and the person's circumstances. The MedlinePlus PID aftercare guidance advises completing prescribed antibiotics and not sharing medicines with another person. A partner should receive their own treatment instructions rather than take leftover tablets or use someone else's prescription.
What if a partner cannot visit a clinic promptly?
Tell the treating healthcare professional if a partner is unlikely to obtain timely care. Depending on the infection, local rules, and the availability of services, the clinician may discuss an alternative way to arrange treatment.
The CDC describes expedited partner therapy (EPT) as an approach in which a healthcare professional provides medication or a prescription for an eligible partner without first examining that partner. EPT is an option for certain chlamydia and gonorrhea cases where permitted and clinically appropriate. It is not available or suitable in every situation, and the clinician should explain its limitations and any need for further testing.
Where available, sexual health services may also help with partner notification. Asking the treating clinician about these options can make it easier to arrange care without relying solely on the person with PID to coordinate every step.
When is it safe to have sex again?
Avoid sexual intercourse until both partners have completed their prescribed antibiotic treatment and the person being treated for PID no longer has symptoms. Follow any additional instructions from the healthcare professional, including advice about test results or further follow-up. The purpose of this pause is to reduce the risk of passing an infection back and forth while treatment is underway.
Using a condom does not replace the recommendation to avoid sex during this treatment period. Both partners should take their medicines exactly as prescribed and complete the full course, even if they begin to feel better before it ends.
If sexual contact occurs before both partners have completed treatment, contact the treating clinician for advice about the next steps. Do not assume that finishing one person's treatment means the other person has also been treated.
What follow-up is needed after partner treatment?
Partner treatment is one part of managing PID. The person diagnosed with PID should also complete their own prescribed antibiotic course and attend recommended follow-up appointments. If symptoms are not improving within 72 hours of starting treatment, the person should be reassessed promptly because the diagnosis or treatment plan may need to be reviewed.
The CDC chlamydia treatment guidelines recommend repeat testing about three months after treatment for chlamydia, regardless of whether the person's partner has been treated. CDC guidance also recommends retesting three months after treatment for gonorrhea-associated PID. This follow-up helps identify repeat infection, including infection acquired again from an untreated or newly infected partner.
Partner treatment should therefore be coordinated with the person's own treatment and follow-up plan. If a partner develops symptoms, receives a positive STI test, or has concerns about medication or possible exposure, they should contact a healthcare professional rather than delay care.